These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30022799)

  • 1. Controlling resistant hypertension.
    Spence JD
    Stroke Vasc Neurol; 2018 Jun; 3(2):69-75. PubMed ID: 30022799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.
    Huang X; Li J; Liu L; Chen G; Yi Y; Li P; Wu Y; Xu Y; Bao H; Yu L; Qin X; Zhang Y; Wang B; Li J; Fan Hou F; Huo Y; Cheng X; Spence JD
    Hypertens Res; 2019 Dec; 42(12):1971-1978. PubMed ID: 31562418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
    Williams B; MacDonald TM; Morant SV; Webb DJ; Sever P; McInnes GT; Ford I; Cruickshank JK; Caulfield MJ; Padmanabhan S; Mackenzie IS; Salsbury J; Brown MJ;
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):464-475. PubMed ID: 29655877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Resistant and Refractory Hypertension.
    Acelajado MC; Hughes ZH; Oparil S; Calhoun DA
    Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa.
    Akintunde A; Nondi J; Gogo K; Jones ESW; Rayner BL; Hackam DG; Spence JD
    Am J Hypertens; 2017 Sep; 30(9):923-930. PubMed ID: 28472315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can resistant hypertension be identified and prevented?
    Solini A; Ruilope LM
    Nat Rev Cardiol; 2013 May; 10(5):293-6. PubMed ID: 23459606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is resistant hypertension and how to diagnose it?].
    Lorthioir A; Belmihoub I; Amar L; Azizi M
    Rev Prat; 2019 Dec; 69(10):1099-1103. PubMed ID: 32237581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    J Hum Hypertens; 2016 Nov; 30(11):657-663. PubMed ID: 26818804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic tailoring of treatment in resistant hypertension.
    Spence JD
    Curr Cardiol Rev; 2010 May; 6(2):119-23. PubMed ID: 21532778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.
    Yugar-Toledo JC; Modolo R; de Faria AP; Moreno H
    Vasc Health Risk Manag; 2017; 13():403-411. PubMed ID: 29081661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of therapeutic lifestyle changes in resistant hypertension.
    Ozemek C; Tiwari S; Sabbahi A; Carbone S; Lavie CJ
    Prog Cardiovasc Dis; 2020; 63(1):4-9. PubMed ID: 31756356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose spironolactone in subjects with resistant hypertension.
    Nishizaka MK; Zaman MA; Calhoun DA
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):925-30. PubMed ID: 14573330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.